Insider Selling: Chemed Co. (NYSE:CHE) CEO Sells 1,000 Shares of Stock

Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Chemed Stock Up 0.1 %

CHE stock traded up $0.84 during trading on Tuesday, reaching $616.16. The company’s stock had a trading volume of 46,936 shares, compared to its average volume of 93,535. The company’s fifty day moving average is $575.36 and its 200-day moving average is $566.98. The company has a market capitalization of $9.02 billion, a P/E ratio of 31.13, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $642.68.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.32%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s dividend payout ratio is currently 10.05%.

Analyst Ratings Changes

CHE has been the topic of a number of recent research reports. Royal Bank of Canada raised their target price on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

Institutional Investors Weigh In On Chemed

Several institutional investors and hedge funds have recently modified their holdings of CHE. Norges Bank bought a new stake in Chemed in the 4th quarter valued at $95,872,000. Freestone Grove Partners LP bought a new stake in shares of Chemed in the fourth quarter worth about $61,664,000. Point72 Asset Management L.P. purchased a new stake in shares of Chemed in the fourth quarter worth about $54,587,000. Raymond James Financial Inc. purchased a new stake in shares of Chemed in the fourth quarter worth about $42,023,000. Finally, Citadel Advisors LLC boosted its stake in Chemed by 197.4% during the fourth quarter. Citadel Advisors LLC now owns 77,143 shares of the company’s stock valued at $40,870,000 after buying an additional 51,206 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.